Lumixyl is a revolutionary peptide technology developed by researchers at Stanford University to improve the appearance of hyperpigmentation, including:

• age spots
• sun spots
• post-inflammatory hyperpigmentation
• uneven skin tone
• photodamage

Preliminary clinical results are being evaluated in large confirmatory trials and demonstrate that topical use of Lumixyl visibly improves mild to moderate hyperpigmentation with excellent volunteer satisfaction in as little as eight weeks.

In addition to its efficacy, Lumixyl is the only skin brightener to offer all of the following benefits in a single product:

• non-irritating and allergenic
• non-toxic
• safe for all skin types
• safe for prolonged use
• easily degraded by the skin
• will not increase skin’s sensitivity to the sun
• stabilised so that it will not lose potency or turn brown after opening
• a luxurious, moisture-rich texture

Lumixyl Topical Brightening cream is a physician-dispensed cosmetic and can be used alone or in combination with other treatments or devices such as tretinoin, laser resurfacing and Dermalinfusion™, respectively, to diminish dark spots, uneven pigmentation and improve overall skin tone. Lumixyl is effective for all skin types.

Whatever your skin tone, Lumixyl works to uniformly even pigment on the surface of the skin and will not cause discolouration or hypopigmentation.

Lumixyl Brightening cream also has the benefits of several moisturising ingredients. In fact, study participants reported visible improvements in overall facial aesthetics in addition to a 50% improvement in the appearance of their hyperpigmentation after 16 weeks!